Abstract:Alzheimer's disease is the most common neurodegenerative disease in the elderly. The pathogenesis of the disease is still unkown. β-amyloid (Aβ) has been demonstrated to involve the molecular mechanism of the disease. The aim of the present study is to investigate the toxic effect of the carboxyl-terminal peptide of β-amyloid precursor protein (APPC31) on Neuro2a cells as well as its role in the toxic process in Neuro2a cells induced by Aβ 42 in vitro. The plasmid vector and the APPC31 construct were transiently transfected into Neuro2a cells respectively by lipofectamine 2000. The viability of the cells was measured by the methyl thiazolyl tetrazolium (MTT) assay at 48 h after transfection, and their morphocytology was observed by 4,6-diamino-2-phenyl indole (DAPI) nucleus staining. Afterword different constructs including vector, WTAPP695, APP(D664A), the amino-terminal peptide of β-amyloid precursor protein (APPΔC31) and APPC31 were transiently transfected into Neuro2a cells respectively via the same method. At 24 h after transfection Aβ42 was added into the culture medium of Neuro2a cells with the desired concentration for another 24 h for cell studies. The viability and morphocytology of the cells were measured by using the MTT assay and DAPI nucleus staining, respectively. When incubated in the absence of Aβ42, the viability of cells transfected with vector and APPC31 construct were respective 0.81 ± 0.10 and 0.88 ± 0.12, and accordingly there was no significant difference between the these two groups (t = -0.78, P = 0.48); meanwhile no obvious cell nuclear morphological changes of apoptosis or death occurred. However when incubated in the presence of Aβ42, the viability of cells transfected with vector, WTAPP695, APP(D664A), APP–3C31 and APPC31 constructs were respective 0.82 ± 0.01, 0.78 ± 0.03, 0.55 ± 0.04, 0.81 ± 0.04, 0.78 ± 0.02 and 0.54 ± 0.02. The viability of cells transfected with WTAPP construct and APPC31 construct decreased significantly (F = 47.53, P<0.05) compared with the control group, meanwhile cells displayed condensed nuclear and even nuclear fragmentation. The overexpression of a certain level of APPC31 in Neuro2a cells failed to cause cell death, but this short peptide enhanced cytotoxicity induced by Aβ42 in Neuro2a cells. Thus, these results provided the experimental basis for the further explication of the pathogenesis of Alzheimer's disease.

Delineating the Mechanism of Alzheimer’s Disease Aβ Peptide Neurotoxicity

Progress in molecular mechanisms of β-amyloid peptides in alzheimer's disease

Molecular and cellular mechanisms for Alzheimer's disease: understanding APP metabolism.

The Recent Updates of Therapeutic Approaches Against Aβ for the Treatment of Alzheimer's Disease

Proteolytic processing of Alzheimer's β-amyloid precursor protein.

Advances in the β-amyloid precursor protein of Alzheimer's disease

Neuritogenic-Neurotoxic Effects of Membrane-Associated Forms ofAmyloid Precursor Prot ein

β-amyloid's neurotoxic mechanisms as defined by in vitro microelectrode arrays: a review

Therapeutic Approaches to Alzheimer'S Disease Through Stimulating of Non-Amyloidogenic Processing of Amyloid Precursor Protein

Modifications and Trafficking of APP in the Pathogenesis of Alzheimer's Disease

Molecular mechanisms in Alzheimer's disease and related potential treatments such as structural target convergence of antibodies and simple organic molecules

Regulation of β cleavage of amyloid precursor protein

The duality of amyloid-β: its role in normal and Alzheimer's disease states

Regulation Of Beta Cleavage Of Amyloid Precursor Protein

An Overview of Several Inhibitors for Alzheimer's Disease: Characterization and Failure

The Amyloid-β Pathway in Alzheimer's Disease

Trafficking Regulation of Proteins in Alzheimer’s Disease

Overview of the Molecular Modalities and Signaling Pathways Intersecting with β-Amyloid and Tau Protein in Alzheimer’s Disease

P2‐142: Toxic Effect of the Carboxyl‐terminal Peptide of Beta‐amyloid Precursor Protein (APPC31) on Neuro2a Cells

Interaction between Aβ and Tau in the Pathogenesis of Alzheimer's Disease

Amyloid-Independent Mechanisms in Alzheimer's Disease Pathogenesis